Effect of chronic garlic intake on platelet function

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2007-004208-11-AT

Enrollment

Unknown

Registered

2007-11-19

Start date

2008-04-28

Completion date

Unknown

Last updated

2016-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

improvement in overall health status by garlic and preoperative setting

Interventions

Trade Name: Kwai 300 mg Product Name: Kwai 300 mg Product Code: 7-00860 Pharmaceutical Form: Tablet INN or Proposed INN: Knoblauchzwiebelpulver Pharmaceutical form of the placebo: Tablet Route of admi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy volunteers ASA I and II age > 18 and =65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: contraindications against Kwai or Voltaren

Design outcomes

Primary

Measure	Time frame
Main Objective: chronic garlic intake (Kwai) inhibits platelet function assessed by impedance aggregometry, Platelet Mapping assay and PFA-100;Secondary Objective: chronic garlic intake potentiates platelet-inhibiting effects of diclofenac (Voltaren);Primary end point(s): garlic decreases the area under the aggregation curve (AUC) in arachidonic acid-induced impedance aggregometry	—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026